Concepedia

Kathrin Härting

KH

2

Publications

448

Citations

2

H-Index

2001

Active since

Affiliations

Klinikum rechts der Isar(Current)

Kathrin Härting is an author at Klinikum rechts der Isar specializing in oncology, ovarian cancer, and tumor biology.

Top concepts

Publications per year

2001–2001

2

Publications

2

Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

Barbara Schmalfeldt, Dieter Prechtel, Kathrin Härting et al. · PubMed · 2001 · 336 citations

, , +14

Expression of Latent Matrix Metalloproteinase 9 (MMP-9) Predicts Survival in Advanced Ovarian Cancer

Ernst Lengyel, Barbara Schmalfeldt, Elisabeth Konik et al. · Gynecologic Oncology · 2001 · 112 citations

, , +7

Rows per page

1–2 of 2